[The clinical study of azacitidine and lenalidomide combination in myelodysplastic neoplasm patients with TP53 mutations]
{{output}}
Objective: To assess the efficacy and safety of azacitidine combined with lenalidomide in MDS patients and explore potential mechanisms of therapeutic response. Methods: Sixteen MDS patients with TP53 mutations received azacitidine plus lenalidomide at ZhongDa... ...
